AAZTA5/AAZTA5-TOC: synthesis and radiochemical evaluation with 68Ga, 44Sc and 177Lu
Abstract Purpose AAZTA (1,4-bis (carboxymethyl)-6-[bis (carboxymethyl)]amino-6-methylperhydro-1,4-diazepine) based chelators were initially developed in the context of magnetic resonance imaging. First radiochemical studies showed the capability of AAZTA to form stable complexes with radiolanthanide...
Main Authors: | Jean-Philippe Sinnes, Johannes Nagel, Frank Rösch |
---|---|
Format: | Article |
Language: | English |
Published: |
SpringerOpen
2019-08-01
|
Series: | EJNMMI Radiopharmacy and Chemistry |
Subjects: | |
Online Access: | http://link.springer.com/article/10.1186/s41181-019-0068-1 |
Similar Items
-
68Ga, 44Sc and 177Lu-labeled AAZTA5-PSMA-617: synthesis, radiolabeling, stability and cell binding compared to DOTA-PSMA-617 analogues
by: Jean-Philippe Sinnes, et al.
Published: (2020-11-01) -
In Vitro Evaluation of the Squaramide-Conjugated Fibroblast Activation Protein Inhibitor-Based Agents AAZTA<sup>5</sup>.SA.FAPi and DOTA.SA.FAPi
by: Euy Sung Moon, et al.
Published: (2021-06-01) -
The Legacy of AAZTA—Synthesis and Coordination Chemistry of Two AAZTA Structural Analogs
by: Federico Forgione, et al.
Published: (2024-08-01) -
AAZTA-Derived Chelators for the Design of Innovative Radiopharmaceuticals with Theranostic Applications
by: Cyril Fersing, et al.
Published: (2022-02-01) -
[<sup>111</sup>In]In/[<sup>177</sup>Lu]Lu-AAZTA<sup>5</sup>-LM4 SST<sub>2</sub>R-Antagonists in Cancer Theranostics: From Preclinical Testing to First Patient Results
by: Berthold A. Nock, et al.
Published: (2023-02-01)